Skip to main content

Table 1 Characteristics of malaria episodes

From: Safety of a fixed-dose combination of artesunate and amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in real-life conditions of use in Côte d’Ivoire

 

N = 15,228

Age (years)

N = 15,225

 Mean ± SD

8.9 ± 13.3

 Median [range]

3 [1–90]

Age by class

N = 15,225

 ≤1 month

2 (<0.01%)

 2–11 months

2111 (13.9%)

 1–5 years

7740 (50.8%)

 6–13 years

2581 (17.0%)

 ≥14 years

2791 (18.3%)

Gender

N = 15,225

 Female

7582 (49.8%)

 Male

7643 (50.2%)

Weight (kg)

N = 15,221

 Mean ± SD

21.6 ± 18.9

 Median [range]

13 [2–116]

Weight by class (kg)

N = 15,221

 <4.5

35 (0.2%)

 4.5 to <9

2704 (17.8%)

 9 to <18

7241 (47.6%)

 18 to <36

2278 (15.0%)

 ≥36

2963 (19.5%)

Clinical signs and symptomsa

N = 15,225

 Fever

13,294 (87.3%)

 Hyperthermia

1608 (10.6%)

 Asthenia

1373 (9.0%)

 Chills

244 (1.6%)

 Headache

3005 (19.7%)

 Dizziness

228 (1.5%)

 Vomiting

2316 (15.2%)

 Diarrhoea

589 (3.9%)

 Abdominal pain

316 (2.1%)

 Decreased appetite/anorexia

2901 (19.1%)

 Joint ankylosis

1223 (8.0%)

 Anaemia

273 (1.8%)

Parasitaemia

N = 14,634

 Positive thick blood smears

11,192 (76.5%)

  1. The N numbers in italics refer to the number of episodes for which the variable of interest was documented
  2. aFrequency counts correspond to number of episodes, since the same patient may have experienced more than one episode. Certain symptoms documented from self-report, such as pain, headache and dizziness, could not be ascertained in young children